Synergy of Coronary Revascularization and Optimal Drug Therapy in Patients With Ischemic Cardiomyopathy and Reduced

B A Kadyrov1

  • 1International Cardiology Center of the Directorate of International Medical Centers, Ashgabat.

Kardiologiia
|February 11, 2026
PubMed

Insights

Combining percutaneous coronary intervention (PCI) with optimal medical therapy (OMT) significantly improves outcomes for patients with ischemic cardiomyopathy (ICM). This approach enhances left ventricular function and reduces mortality and hospitalizations.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Interventional Cardiology

Background:

  • Ischemic cardiomyopathy (ICM) with reduced left ventricular ejection fraction (LVEF) is a severe form of chronic heart failure (CHF) with high mortality.
  • Optimal treatment strategies, particularly the role of coronary revascularization alongside optimal medical therapy (OMT), are under active investigation.
  • Understanding the impact on left ventricular (LV) reverse remodeling and long-term prognosis is crucial.

Purpose of the Study:

  • To evaluate the clinical, functional, and prognostic outcomes of combining percutaneous coronary intervention (PCI) with OMT in patients with ICM and reduced LVEF.
  • To assess the effect of PCI+OMT on LV reverse remodeling.
  • To compare outcomes between patients treated with PCI+OMT versus OMT alone.

Main Methods:

  • Retrospective cohort study of 561 patients with ICM and LVEF <40%.
  • Patients were divided into a revascularization group (PCI+OMT, n=281) and an OMT group (n=280).
  • Transthoracic echocardiography (ECHO) was used to assess cardiac structure and function over a 24-month follow-up period.

Main Results:

  • The PCI+OMT group showed significantly greater improvement in LVEF (+10.7% vs. +2.1%) and a lower proportion of severe mitral regurgitation (5.3% vs. 16.1%) at 24 months.
  • Overall mortality was significantly lower in the PCI+OMT group (10.7% vs. 23.2%).
  • CHF-related hospitalization rates were also significantly reduced in the PCI+OMT group (17.8% vs. 33.9%).

Conclusions:

  • The combination of PCI and OMT promotes significant recovery of myocardial contractility and LV reverse remodeling.
  • This integrated approach leads to regression of functional mitral regurgitation.
  • PCI+OMT significantly reduces mid-term overall mortality and hospitalizations due to decompensated CHF.
Abstract

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
304
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
587
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269